1. Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs
2. US Food and Drug Administration.Exposure‐response relationships—study design data analysis and regulatory applications guidance for industry. (2003). Accessed April 2003.
3. US Food and Drug Administration.General clinical pharmacology: considerations for pediatric studies for drugs and biological products guidance for industry. (2014). Accessed December 2014.
4. E11 International Conference on Harmonisation (ICH).Clinical investigation of medicinal products in the paediatric population. Note for guidance on clinical investigation of medicinal products in the paediatric population (CPMP/ICH/2711/99). . Accessed January 2011.
5. Dosing in Children: A Critical Review of the Pharmacokinetic Allometric Scaling and Modelling Approaches in Paediatric Drug Development and Clinical Settings